1. Home
  2. SCOR vs CALC Comparison

SCOR vs CALC Comparison

Compare SCOR & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo comScore Inc.

SCOR

comScore Inc.

HOLD

Current Price

$7.20

Market Cap

32.8M

ML Signal

HOLD

Logo CalciMedica Inc.

CALC

CalciMedica Inc.

HOLD

Current Price

$4.88

Market Cap

63.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCOR
CALC
Founded
1999
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.8M
63.0M
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
SCOR
CALC
Price
$7.20
$4.88
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$14.50
AVG Volume (30 Days)
7.2K
135.7K
Earning Date
11-04-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$358,940,000.00
N/A
Revenue This Year
$2.01
N/A
Revenue Next Year
$1.57
N/A
P/E Ratio
N/A
N/A
Revenue Growth
0.77
N/A
52 Week Low
$4.39
$1.42
52 Week High
$10.18
$5.34

Technical Indicators

Market Signals
Indicator
SCOR
CALC
Relative Strength Index (RSI) 53.41 64.91
Support Level $6.51 $4.24
Resistance Level $7.15 $5.34
Average True Range (ATR) 0.37 0.42
MACD 0.07 0.03
Stochastic Oscillator 81.25 66.80

Price Performance

Historical Comparison
SCOR
CALC

About SCOR comScore Inc.

comScore Inc is a United States-based information and analytics company that measures advertising, content, and the consumer audiences of each across media platforms. The platforms it measures include televisions, mobile devices, computers, tablets, CTV devices, and movie theaters. The company generates almost all its revenue from the United States, followed by Europe, Latin America, Canada, and other regions. It provides solutions for the automotive, digital media, financial services, pharmaceutical, retail, technology, travel, and other industries.

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.

Share on Social Networks: